Gfrerer Lisa, Lans Jonathan, Faulkner Heather R, Nota Sjoerd, Bot Arjan G J, Austen William Gerald
Boston, Mass.; and Amsterdam, The Netherlands.
From the Division of Plastic and Reconstructive Surgery, the Department of Orthopedic Surgery, Hand and Upper Extremity Service, Massachusetts General Hospital, Harvard Medical School; and the Orthopaedic Research Center Amsterdam, Academic Medical Center.
Plast Reconstr Surg. 2018 Jan;141(1):169-174. doi: 10.1097/PRS.0000000000003955.
Candidates for migraine surgery are chronic pain patients with significant disability. Currently, migraine-specific questionnaires are used to evaluate these patients. Analysis tools widely used in evaluation of better understood pain conditions are not typically applied. This is the first study to include a commonly used pain questionnaire, the Pain Self-Efficacy Questionnaire (PSEQ) that is used to determine patients' pain coping abilities and function. It is an important predictor of pain intensity/disability in patients with musculoskeletal pain, as low scores have been associated with poor outcome.
Ninety patients were enrolled prospectively and completed the Migraine Headache Index and PSEQ preoperatively and at 12 months postoperatively. Scores were evaluated using paired t tests and Pearson correlation. Representative PSEQ scores for other pain conditions were chosen for score comparison.
All scores improved significantly from baseline (p < 0.01). Mean preoperative pain coping score (PSEQ) was 18.2 ± 11.7, which is extremely poor compared with scores reported for other pain conditions. Improvement of PSEQ score after migraine surgery was higher than seen in other pain conditions after treatment (112 percent). Preoperative PSEQ scores did not influence postoperative outcome.
The PSEQ successfully demonstrates the extent of debility in migraine surgery patients by putting migraine pain in perspective with other known pain conditions. It further evaluates functional status, rather than improvement in migraine characteristics, which significantly adds to our understanding of outcome. Poor preoperative PSEQ scores do not influence outcome and should not be used to determine eligibility for migraine surgery.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
偏头痛手术的候选者是患有严重残疾的慢性疼痛患者。目前,使用偏头痛专用问卷来评估这些患者。在评估更易理解的疼痛状况时广泛使用的分析工具通常未被应用。这是第一项纳入常用疼痛问卷——疼痛自我效能问卷(PSEQ)的研究,该问卷用于确定患者的疼痛应对能力和功能。它是肌肉骨骼疼痛患者疼痛强度/残疾程度的重要预测指标,因为低分与不良预后相关。
前瞻性纳入90例患者,术前及术后12个月完成偏头痛头痛指数和PSEQ。使用配对t检验和Pearson相关性评估分数。选择其他疼痛状况的代表性PSEQ分数进行分数比较。
所有分数均较基线显著改善(p < 0.01)。术前平均疼痛应对分数(PSEQ)为18.2 ± 11.7,与其他疼痛状况报告的分数相比极差。偏头痛手术后PSEQ分数的改善高于其他疼痛状况治疗后的改善(112%)。术前PSEQ分数不影响术后结果。
PSEQ通过将偏头痛疼痛与其他已知疼痛状况相比较,成功地展示了偏头痛手术患者的虚弱程度。它进一步评估功能状态,而非偏头痛特征的改善,这显著增进了我们对结果的理解。术前PSEQ分数低不影响结果,不应将其用于确定偏头痛手术的资格。
临床问题/证据水平:治疗性,IV级。